Click on headlines below to download research

New formulations extend Treakisym patent life
SymBio Pharmaceuticals | 02/11/2017

SymBio has substantially increased the value of its Treakisym franchise through in-licensing novel bendamustine formulations from Eagle Pharmaceuticals…

New formulations extend Treakisym patent life
SymBio Pharmaceuticals | 23/10/2017

SymBio has substantially increased the value of its Treakisym franchise through in-licencing novel bendamustine formulations from Eagle Pharmaceuticals…

Moving ahead on all fronts
SymBio Pharmaceuticals | 27/02/2017

During 2017 we expect updates on all three of SymBio’s main assets. We expect Treakisym sales growth via partner Eisai following approvals during…